This compound is a nitrosamine impurity associated with the pharmaceutical compound sitagliptin. It is primarily recognized as a process-related impurity in pharmaceutical manufacturing and quality control.
Portée du contenu: Les informations de cette page concernent l'identification chimique ainsi que les contextes d'approvisionnement industriel, de recherche et de production. Elles ne constituent ni une allégation thérapeutique, ni un avis médical, ni une notice d'utilisation médicamenteuse.
Approvisionnement ou fourniture de ce composé?
Publiez votre inventaire ou une demande d'achat
CAS 2892260-32-9
2-Amino-4'-chlorobenzophenone
pharmaceutical intermediate
8-benzyl-8-azabicyclo[3.2.1]octan-3-one
pharmaceutical intermediate for tropane derivatives
2-(3,5-bis(trifluoromethyl)phenyl)-2-methylpropanoic acid
Pharmaceutical intermediate for netupitant synthesis
L-Methionine ethyl ester hydrochloride
Pharmaceutical intermediate
3-(TRIFLUOROMETHYL)-5,6,7,8-TETRAHYDRO-[1,2,4]TRIAZOLO[4,3-A]PYRAZINE
Pharmaceutical intermediate for sitagliptin
3-(trifluoromethyl)-5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyrazine hydrochloride
Pharmaceutical intermediate
7-nitroso-3-(trifluoromethyl)-6,8-dihydro-5H-[1,2,4]triazolo[4,3-a]pyrazine
HPLUAAVIJHAQQZ-UHFFFAOYSA-N
C1CN2C(=NN=C2C(F)(F)F)CN1N=O